E7080 (Lenvatinib)
99%
- Product Code: 46739
CAS:
417716-92-8
| Molecular Weight: | 426.85 g./mol | Molecular Formula: | C₂₁H₁₉ClN₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16038644 | |
| Melting Point: | Boiling Point: | 627.242°C | |
| Density: | 1.469g/mL | Storage Condition: | 2-8℃ |
Product Description:
Lenvatinib is primarily used in the treatment of certain types of cancer. It is approved for use in advanced or metastatic thyroid cancer that is resistant to radioactive iodine. It is also utilized in combination with other drugs for the treatment of advanced renal cell carcinoma, offering an option for patients who have not responded to prior therapies. Additionally, Lenvatinib is indicated for unresectable hepatocellular carcinoma, providing a systemic treatment option for patients with this challenging form of liver cancer. Its mechanism involves inhibiting multiple kinase enzymes, which helps in slowing the progression of these cancers by targeting the blood vessels that supply tumors and the tumor cells themselves.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white solid |
| PURITY | 98.5 |
| PROTON NMR SPECTRUM | Consisten t with structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿1,180.00 |
+
-
|
| 1.000 | 10-20 days | ฿5,180.00 |
+
-
|
| 5.000 | 10-20 days | ฿22,880.00 |
+
-
|
E7080 (Lenvatinib)
Lenvatinib is primarily used in the treatment of certain types of cancer. It is approved for use in advanced or metastatic thyroid cancer that is resistant to radioactive iodine. It is also utilized in combination with other drugs for the treatment of advanced renal cell carcinoma, offering an option for patients who have not responded to prior therapies. Additionally, Lenvatinib is indicated for unresectable hepatocellular carcinoma, providing a systemic treatment option for patients with this challenging form of liver cancer. Its mechanism involves inhibiting multiple kinase enzymes, which helps in slowing the progression of these cancers by targeting the blood vessels that supply tumors and the tumor cells themselves.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :